Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M Hann

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Blood|September 26, 2000
Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XIK A Wheeler, S M Richards, C C Bailey, et al.
Archives of Disease in Childhood|September 25, 2001
Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatmentJ M Chessells, G Harrison, S M Richards, et al.
British Journal of Cancer|April 26, 2000
Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocolA Atra, J D Imeson, R Hobson, et al.
Blood|May 1, 1996
Severe perinatal thrombosis in double and triple heterozygous offspring of a family segregating two independent protein S mutations and a protein C mutationC J Formstone, P J Hallam, E G Tuddenham, et al.
British Journal of Haematology|May 1, 1992
Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood LeukaemiaJ S Lilleyman, I M Hann, R F Stevens, et al.
British Journal of Haematology|June 1, 1997
Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood LeukaemiaJ S Lilleyman, B E Gibson, R F Stevens, et al.
Blood|April 1, 1995
Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring systemS J Passmore, I M Hann, C A Stiller, et al.
Leukemia|May 1, 1988
Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiationA K Burnett, I M Hann, A G Robertson, et al.
Leukemia|November 24, 2005
Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trialsB E S Gibson, K Wheatley, I M Hann, et al.
British Journal of Haematology|October 16, 1999
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working PartiesK Wheatley, A K Burnett, A H Goldstone, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Blood|September 26, 2000
Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XIK A Wheeler, S M Richards, C C Bailey, et al.
Archives of Disease in Childhood|September 25, 2001
Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatmentJ M Chessells, G Harrison, S M Richards, et al.
British Journal of Cancer|April 26, 2000
Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocolA Atra, J D Imeson, R Hobson, et al.
Blood|May 1, 1996
Severe perinatal thrombosis in double and triple heterozygous offspring of a family segregating two independent protein S mutations and a protein C mutationC J Formstone, P J Hallam, E G Tuddenham, et al.
British Journal of Haematology|May 1, 1992
Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood LeukaemiaJ S Lilleyman, I M Hann, R F Stevens, et al.
British Journal of Haematology|June 1, 1997
Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood LeukaemiaJ S Lilleyman, B E Gibson, R F Stevens, et al.
Blood|April 1, 1995
Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring systemS J Passmore, I M Hann, C A Stiller, et al.
Leukemia|May 1, 1988
Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiationA K Burnett, I M Hann, A G Robertson, et al.
Leukemia|November 24, 2005
Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trialsB E S Gibson, K Wheatley, I M Hann, et al.
British Journal of Haematology|October 16, 1999
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working PartiesK Wheatley, A K Burnett, A H Goldstone, et al.
Pageof 9